Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.08.31.748412

BARCS: beta-binomial regression for multivariate CRISPR screen design

Abstract

Pooled CRISPR screens increasingly use longitudinal, donor-adjusted, and factorial designs, but beta-binomial screen methods have largely remained limited to pairwise comparisons. BARCS extends the library-total-conditional beta-binomial model to guide-level regression with an arbitrary design matrix, enabling direct estimation of time, covariate, and interaction effects. In four replicate-complete Cas13 screens, adding the intermediate time point modestly improved essential-gene recovery. Applying the same non-targeting-control scaling rule to BARCS, MAGeCK-MLE, edgeR-QL, DESeq2, and limma--voom produced similar calibration across all five methods, while the four alternatives ranked essential genes more strongly than BARCS. In an ordered-bin IL2RA screen, donor-adjusted BARCS recovered more validated regulators with fewer total calls than the matched four-bin MAGeCK-MLE fit, and cross-fitted controls exposed excess guide-level significance. Simulations showed gains from dispersion moderation and control-based denominators, but seed-specific results exposed denominator sensitivity and a null grid localized substantial gene-level error to correlated-guide aggregation rather than dispersion alone. Aggregation-matched control scaling reduced but did not eliminate this error. An external audit prompted by concerns about beta-binomial false discoveries showed that the reported CB2 null-discovery count disappeared when full-library totals were restored. This corrected one denominator-dependent result but did not refute the broader calibration concern; nominal-level calibration remained unresolved. BARCS therefore contributes a multivariable extension of the library-total-conditional beta-binomial model together with an explicit account of where its inference is valid: guide-level coefficients are supported by independent biological libraries, whereas gene-level summaries and partitioned-bin designs require correlation-aware aggregation or joint modelling that the present implementation provides diagnostically rather than generatively. We report this boundary because complex pooled designs make it consequential, not because it is unique to the beta-binomial model.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Lee, K.-W., Jeong, H.-H.. 2026-09-01. BARCS: beta-binomial regression for multivariate CRISPR screen design. https://doi.org/10.64898/2026.08.31.748412

Cite the original work for its findings. Save a collection to share your selection of sources.

Discover connections

Connections use source metadata and explicit phrase matches, not verified experimental comparisons.

KEEP EXPLORING

Related preprints

Carrier-Limited Release Risk in Electrospun Nanofibers for Regenerative Endodontics: Constraint Discovery from 25 Formulations

Regenerative endodontics needs an intracanal carrier that keeps disinfecting across a dressing interval that clinicians schedule at one to four weeks, without harming the stem cells that rebuild the pulp. We ask what one completed 25-formulation electrospinning campaign of poly(vinylpyrrolidone) (PVP) fibers carrying metronidazole, ciprofloxacin, minocycline and Ca(OH)2 can decide, and use machine learning for constraint discovery and decision support rather than as a new predictor. After an audit against the source thesis, logistic regression predicts fine-fiber formation at 96% leave-one-out accuracy, but a one-threshold rule does as well, the gain over the 80% majority baseline is not significant (exact McNemar p = 0.125), and accuracy falls to 84% when mixture loading is encoded per component. Diameter models interpolate within formulation families (ridge MAE 193 nm, 95% CI 96 to 317 nm) and fail across them (R^2 < 0). Because the campaign never measured release, we assemble a same-drug, cross-carrier evidence table: 17 bounded metronidazole and ciprofloxacin observations from seven studies, with two-sided censoring. Water-soluble carriers (PVP, PVA) completed release within 80 h (PVP within 8 h); no water-insoluble monolithic carrier reached 90% within its observation window, releasing 1.5 to 50%; both within-study comparisons separate at matched loading; and blend, core-shell and thick-mat architectures released over 3 to 28 days. The PVP mats therefore carry a carrier-limited release risk, not a proven ceiling, and one dissolution experiment can confirm or overturn it. A censoring-aware screen keeps three necessarily and one possibly nondominated formulation, and fixed-budget replays show that uncertainty sampling finds failed formulations sooner, except the one it is confidently wrong about.

bioinformatics↗

CellMethMarker provides an integrated database of human cell- and tissue-type-specific DNA methylation markers

Cell- and tissue-type-specific DNA methylation markers provide epigenetic signatures of cellular identity and are widely used to infer cellular origin from bulk and single-cell methylomes. Existing resources mainly emphasize disease-associated biomarkers, methylome atlases, genomic annotations or RNA-based cell markers, leaving an unmet need for an integrated region-level resource dedicated to such markers. Here we present CellMethMarker (http://gu-zhanglab.hfcas.ac.cn/CellMethMarker), a curated database integrating 347,514 de novo markers derived from uniformly processed whole-genome and reduced-representation bisulfite sequencing datasets, 2,203,507 literature-derived marker records and harmonized metadata for 2,810 samples. CellMethMarker enables cell- and tissue-centered marker retrieval, coordinate-based search, genome-browser visualization, interactive methylation analysis and data download. In an independent single-cell methylome atlas, these markers recover the expected cell-type-associated methylation patterns, and a platform-matched reference built from them lowers the mean deconvolution error from 0.365 to 0.144. CellMethMarker therefore links region-level DNA methylation variation to cellular identity and supports methylome-based cell-type annotation and deconvolution.

bioinformatics↗

IG-28 enables identification and quantification of high-confidence isoforms from large bulk and single-cell full-length cDNA datasets

The technology to sequence full-length transcriptomes from bulk and single-cell samples has rapidly advanced. As a result, full-length cDNA datasets now reach billions of reads in size which is beyond the capability of most established isoform identification tools. Here, we introduce IG-28 which addresses this challenge with its capability to process and analyze large fl-cDNA datasets fast and using minimal computational resources. In contrast to its predecessor Mandalorion, IG-28 is not limited to bulk fl-cDNA but is capable of parsing, processing, and analyzing single-cell fl-cDNA datasets. It does so in a lightweight, flexible manner, integrating seamlessly with established scRNA-seq analysis workflows. We benchmarked IG-28 against a variety of established and new isoform identification tools using several bulk and a complex single-cell fl-cDNA dataset and found that IG-28 consistently outperformed the other tools by identifying high-confidence public isoforms.

bioinformatics↗